The prevalence of atopy in patients with familial mediterranean fever and behçet's disease

Clinical and Experimental Rheumatology

Volumn 31, Issue SUPPL.77, 2013, Pages

  Yazici, Ayten ^a   Gonullu, Emel Orge ^a   Kardes, Bülent ^a   Cefle, Ayse ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

Atopy; Beh et's disease; Familial Mediterranean fever

Indexed keywords

IMMUNOGLOBULIN E;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; ATOPY; BEHCET DISEASE; CONTROLLED STUDY; EOSINOPHIL COUNT; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SKIN TEST; TH2 CELL;

ADULT; ANALYSIS OF VARIANCE; BEHCET SYNDROME; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; EOSINOPHILS; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; INTRADERMAL TESTS; MALE; PREVALENCE; TURKEY; YOUNG ADULT;

EID: 84884945170     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. SACKESEN C, BAKKALOGLU A, SEKEREL BE et al.: Decreased prevalence of atopy in pediatric patients with familial Mediterranean fever. Ann Rheum Dis 2004; 63: 187-90.
2. GASTON JSH: Will the increasing pevalence of atopy have a favourable impact on rheumatoid arthritis? Ann Rheum Dis 1998; 57: 265-7.
3. BEN-CHETRIT E, LEVY M: Familial Mediterranean fever. Lancet 1998; 351: 659-64.
4. The IntTernatiTIonal FMF ConsortiTIum: Ancient missense mutations in a new member of the RoRet gene familya re likely to cause familial Mediterranean fever. Cell 1997; 90: 797-807.
5. CENTOLA M, WOOD G, FRUCHT DM et al.: The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 2000; 95: 3223-31.
6. GÜL A: Behçet's disease: an update on the pathogenesis. Clin Exp Rheumatol 2001; 19 (Suppl. 24): S6-12.
7. HATEMI G, SEYAHI E, FRESKO I, HAMURYUDAN V: Behçet's syndrome: a critical digest of the recent literature. Clin Exp Rheumatol 2012; 30 (Suppl. 72): S80-9.
8. SHIMIZU J, IZUMI T, ARIMITSU N et al.: Skewed TGFβ/Smad signalling pathway in T cells in patients with Behçet's disease. Clin Exp Rheumatol 2012; 30 (Suppl. 72): S35-9.
9. CHANG HK, LEE SS, KIM JW et al.: The prevalence of atopy and atopic diseases in Behçet' disease. Clin Exp Rheumatol 2003; 21 (Suppl. 30): S31-4.
10. IntTernatiTIonal SstTudy Group fFor BehçetT's diIsease: Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078-80.
11. RUDWALEIT A, ANDERMANN B, ALTEN R et al.: Atopic disorders in ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis 2002; 61: 968-74.
12. DANON YL, LAOR A, SHLEZINGER M, ZEMER D: Decreased incidence of asthma in patients with familial Mediterranean fever. Isr J Med Sci 1990; 26: 459-60.
13. BRENNER-ULLMAN A, MELZER-OFIR H, DANIELS M, SHOHAT M: Possible protection against asthma in heterozygotes for familial Mediterranean fever. Am J Med Genet 1994; 53: 172-5.
14. DINÇ A, KARAAYVAZ M, CALISKANER AZ, PAY S, ERDEM H, TURAN M: Dermographism and atopy in the patients with Behçet's disease. J Investig Allergol Clin Immunol 2000; 10: 368-7.
15. CENGIZ K: Serum IgE concentrations in complete Behçet's disease. J Clin Pathol 1990; 43: 262.
16. KALPAKLIOGLU AF, GÜRBÜZ L, GÜRLER A, DEMIREL YS: Bronchial hyperreactivity and immunoglobulin E in Behçet's disease. Allergol Immunopathol 1997; 25: 182-8.
17. GUL U, GONUL M, CAKMAK SK, KILIC A, OLCAY I: Atopy in Behçet's disease. Int J Dermatol 2006; 45: 1011-3.